{
    "title": "113_hr4287",
    "content": "The \"Independent Innovator and Repurposing Act\" may extend the patent term for using biological products. The \"Extension for Regulatory Delay\" allows a 5-year extension for patents on methods using biological products if certain conditions are met. The owner must submit an application with specific details to the Director for consideration. The application for a patent extension on methods using biological products must include details such as the identity of the biological product, the patent being extended, proof of independent innovator status, and a filed application for commercial marketing. A minimum of 10 years must have passed since the original submission. The application for a patent extension on methods using biological products must include details such as the identity of the biological product, proof of independent innovator status, and a filed application for commercial marketing. A minimum of 10 years must have passed since the original submission for an exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act. The Director will determine the eligibility for extension based on the information provided in the application. The Director will determine patent extension eligibility based on the application submitted. If approved, a certificate of extension will be issued for 5 years, which will be considered part of the original patent. If the patent would expire before a decision is made, interim extensions of up to one year may be granted. The Director may extend the term of a patent for up to one year if the patent is eligible for extension. Definitions include \"biological product\" and \"Director.\" An \"independent innovator\" is defined as a person or entity with a method of use patent for a biological product who is not affiliated with a holder of a marketing application approved under the Public Health Service Act. The term \"affiliated\" in relation to a qualified small business with fewer than 500 employees, means any employment, control, or common ownership relationship, direct or indirect, with the holder of a marketing application approved under the Public Health Service Act. This section takes effect on the date specified. The section applies to the holder of a marketing application approved under the Public Health Service Act for the commercial marketing of a biological product. It takes effect on the enactment date and applies to any unexpired patent issued before or after that date."
}